Images are character representations of Demodex mites.

YOUR XDEMVY^® SUCCESS STORY MATTERS

Uplift Someone Else on a Similar DB Journey

Sharing your XDEMVY experience is about more than just recounting your personal journey; it’s about offering support and building a community. Fill out the form below to share your XDEMVY experience. And please include a photo of yourself!

(*Fields marked with asterisks are required.)

To ensure the privacy of individuals, images will not be identified using full names or other personal identifying information without written approval from the photographed subject.

close up of illustrated brown eye with eyelids and eyelashes

Name*

Email*

Phone Number

Story*

Choose photo (optional):

This is optional if you’re shy. If not—we’d love to see your face.

SELECT PHOTO

By submitting a photo, you give Tarsus permission to use your photo in conjunction with your story.

I have taken XDEMVY.

Yes! Please contact me at this email address with additional information related to XDEMVY and Demodex blepharitis (DB). By subscribing, I confirm that I agree to the Terms of Use and Privacy Policy.*

By checking this box, I agree to receive promotional text messages. I understand that carrier rates may apply. I understand I do not need to agree to receive SMS/text messages as a condition of signing up to receive information about XDEMVY and Demodex blepharitis (DB).

Illustrated demodex mite peers around a bottle of XDEMVY next to party favors in a puddle of liquid with text reading party’s over

One drop per eye, twice a day (~12 hours apart), for 6 weeks.

Important Safety Information

Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. 

Handling the Container: Avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice: Immediately seek a physician’s advice concerning the continued use of XDEMVY if you develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions. 

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals at 1-888-421-4002 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

YOUR XDEMVY® SUCCESS STORY MATTERS

Uplift Someone Else on a Similar DB Journey

Join XDEMVY on Facebook

Follow XDEMVY on Instagram

You are leaving the XDEMVY® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY® patient website and going to the healthcare professional website.

You are leaving the XDEMVY® patient website.

Are you a US healthcare professional?

YOUR XDEMVY^® SUCCESS STORY MATTERS

You are leaving the XDEMVY^® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY^® patient website and going to the healthcare professional website.

You are leaving the XDEMVY^® patient website.